Elderberry: Clinical Evidence & Substantiation Summary
What Is Elderberry?
Elderberry (Sambucus nigra) extract is one of the most popular immune-support botanicals, with clinical evidence supporting its use for reducing the duration and severity of upper respiratory infections, particularly colds and influenza.
Mechanism of action: Elderberry's anthocyanins and other flavonoids exhibit direct antiviral activity by inhibiting viral adhesion and entry into host cells. They also stimulate cytokine production (IL-6, IL-8, TNF-α), enhancing innate immune response, while modulating pro-inflammatory pathways.
Clinical Evidence Summary
Below are 5 key clinical studies on Elderberry. Nutra Comp analyses 14+ studies in its full clinical evidence report.
Black elderberry supplementation for upper respiratory symptoms: a meta-analysis
Population: 4 RCTs, 180 participants
Key finding: Elderberry supplementation significantly reduced upper respiratory symptom duration (mean reduction: 2.1 days, p<0.001) and severity.
Elderberry extract and influenza: a randomised trial
Population: 312 air travellers
Key finding: Elderberry extract significantly reduced cold episode duration (4.75 vs 6.88 days, p=0.02) and severity in travellers.
In vitro antiviral activity of elderberry extract
Population: Multiple viral strains
Key finding: Elderberry extract demonstrated inhibition of influenza A and B virus replication at extract concentrations achievable with standard supplementation.
Elderberry and immune biomarkers in humans
Population: 52 healthy adults
Key finding: Elderberry extract (600 mg/day for 10 days) significantly increased antibody titers against influenza following vaccination (p=0.04).
Safety and tolerability of elderberry supplementation
Population: All available clinical data
Key finding: Elderberry supplementation demonstrated excellent safety and tolerability at standard doses, with adverse events comparable to placebo.
Evidence-Based Structure–Function Claims
Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.
Get the full substantiation report for Elderberry
Includes all 14+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.
Join Waitlist for Full AccessRelated Ingredients
Key Terms
Frequently Asked Questions
Is elderberry FDA approved?
Elderberry is sold as a dietary supplement and does not require FDA approval. Raw elderberries should never be consumed uncooked due to cyanogenic glycoside content; commercial extracts are heat-processed.
What are the most studied benefits?
The strongest evidence supports elderberry for reducing the duration and severity of upper respiratory infections, particularly colds and influenza.
What dosage is used?
Most studies use 300–600 mg/day of standardised extract or 15 mL/day of syrup for prevention, with higher doses (4× daily) during acute symptoms.
Stop Spending Weeks on Substantiation
Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.
Join the Waitlist